COPENHAGEN, Dec 13: Danish pharmaceutical group H Lundbeck A/S said on Wednesday the US Food and Drug Administration (FDA) has accepted the submission of a new drug application for an antidepressant. Lundbeck and its Japanese partner Takeda Pharmaceutical Co Ltdsubmitted the new antidepressant, vortioxetine, for regulatory approval in the United States in October. (agencies)
Trending Now
E-Paper
Follow our WhatsApp channel